KOD icon

Kodiak Sciences

7.30 USD
-0.50
6.41%
At close Jul 30, 4:00 PM EDT
After hours
7.30
+0.00
0.00%
1 day
-6.41%
5 days
6.57%
1 month
95.71%
3 months
67.43%
6 months
7.35%
Year to date
-15.31%
1 year
153.47%
5 years
-84.63%
10 years
-28.15%
 

About: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Employees: 113

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

2,700% more call options, than puts

Call options by funds: $56K | Put options by funds: $2K

33% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 30

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

1.54% more ownership

Funds ownership: 79.92% [Q4 2024] → 81.46% (+1.54%) [Q1 2025]

0% more funds holding

Funds holding: 106 [Q4 2024] → 106 (+0) [Q1 2025]

71% less capital invested

Capital invested by funds: $418M [Q4 2024] → $120M (-$298M) [Q1 2025]

100% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 0 (-2) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for KOD.

Financial journalist opinion

Neutral
PRNewsWire
2 weeks ago
Kodiak Sciences to Host Investor R&D Day on July 16, 2025
PALO ALTO, Calif.  , July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics, announced today it will host an investor R&D Day webcast on Wednesday, July 16, 2025, from 4:00 pm ET to 5:30 pm ET.
Kodiak Sciences to Host Investor R&D Day on July 16, 2025
Neutral
PRNewsWire
1 month ago
Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society
PALO ALTO, Calif. , June 25, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management along with key opinion leaders will present KSI-101 highlights at the 2025 Congress of the International Ocular Inflammation Society (IOIS) in Rio de Janeiro, Brazil on Friday, June 27, 2025.
Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society
Positive
Zacks Investment Research
1 month ago
Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report?
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock?
Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report?
Neutral
PRNewsWire
2 months ago
Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference
PALO ALTO, Calif. , May 29, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that Victor Perlroth, M.D.
Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference
Negative
Zacks Investment Research
2 months ago
Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus
KOD reports a wider-than-expected loss for the first quarter of 2025. The company provides updates regarding its pipeline development plans.
Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus
Neutral
PRNewsWire
2 months ago
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results
PALO ALTO, Calif. , May 14, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the first quarter ended March 31, 2025.
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results
Neutral
PRNewsWire
2 months ago
Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases
PALO ALTO, Calif. , May 1, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that seven scientific presentations on its research programs will be made at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting, being held from May 4-8 in Salt Lake City, Utah.
Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases
Positive
Zacks Investment Research
3 months ago
Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)
Kodiak Sciences (KOD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)
Negative
Zacks Investment Research
4 months ago
Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus
KOD reports a narrower-than-expected loss for the fourth quarter of 2024. The company provides updates regarding its pipeline development plans.
Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus
Neutral
PRNewsWire
4 months ago
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
PALO ALTO, Calif. , March 27, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2024.
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Charts implemented using Lightweight Charts™